AHS Cancer Control Alberta

πŸ‡¨πŸ‡¦Canada
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Virtual Overdose Response

Not Applicable
Withdrawn
Conditions
Drug Overdose
Interventions
Behavioral: Virtual Overdose Response
First Posted Date
2020-05-18
Last Posted Date
2021-05-25
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT04391192
Locations
πŸ‡¨πŸ‡¦

Undetermined, Calgary, Alberta, Canada

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Not Applicable
Recruiting
Conditions
Cancer
Interventions
Device: MR scan with the Alberta linac-MR P3 system
First Posted Date
2020-04-24
Last Posted Date
2024-01-30
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
100
Registration Number
NCT04358913
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Immune-Mediated Pathophysiology And Clinical Triage Program

Phase 2
Recruiting
Conditions
Arthralgia
Arthritis
Interventions
Other: Placebo
Drug: Hydroxychloroquine
First Posted Date
2020-04-21
Last Posted Date
2024-01-31
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
46
Registration Number
NCT04354649
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation

First Posted Date
2020-03-31
Last Posted Date
2023-01-11
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
4
Registration Number
NCT04328246
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

Phase 2
Recruiting
Conditions
Myeloma
Myeloma Multiple
Interventions
Drug: Bortezomib Injection
First Posted Date
2020-02-13
Last Posted Date
2024-10-07
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
100
Registration Number
NCT04268199
Locations
πŸ‡¨πŸ‡¦

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions

First Posted Date
2020-01-27
Last Posted Date
2024-06-12
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
64
Registration Number
NCT04242589
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Nutritional Supplement to Support People With Non-small Cell Lung Cancer

First Posted Date
2019-11-25
Last Posted Date
2024-06-12
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
60
Registration Number
NCT04175769
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer

First Posted Date
2019-11-04
Last Posted Date
2020-06-11
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT04149444
Locations
πŸ‡¨πŸ‡¦

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

Phase 2
Completed
Conditions
SCCHN
First Posted Date
2019-09-27
Last Posted Date
2024-06-14
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
6
Registration Number
NCT04107103
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

First Posted Date
2019-09-26
Last Posted Date
2024-03-04
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
32
Registration Number
NCT04104945
Locations
πŸ‡¨πŸ‡¦

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy